Rhythm Pharmaceuticals Inc
NASDAQ:RYTM

Watchlist Manager
Rhythm Pharmaceuticals Inc Logo
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
Watchlist
Price: 114.5 USD -2.65% Market Closed
Market Cap: 7.6B USD

Wall Street
Price Targets

RYTM Price Targets Summary
Rhythm Pharmaceuticals Inc

Wall Street analysts forecast RYTM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RYTM is 128.38 USD with a low forecast of 111.1 USD and a high forecast of 148.05 USD.

Lowest
Price Target
111.1 USD
3% Downside
Average
Price Target
128.38 USD
12% Upside
Highest
Price Target
148.05 USD
29% Upside
Rhythm Pharmaceuticals Inc Competitors:
Price Targets
300294
China Resources Boya Bio pharmaceutical Group Co Ltd
43% Upside
SOBI
Swedish Orphan Biovitrum AB (publ)
10% Upside
TECX
AVROBIO Inc
318% Upside
ONCO
Oncopeptides AB
1% Downside
ADOC
Adocia SA
119% Upside
CSL
CSL Ltd
36% Upside
AVCT
Avacta Group PLC
6% Upside
005690
Pharmicell Co Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
Rhythm Pharmaceuticals Inc

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 62%.

N/A
Past Growth
62%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Rhythm Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-38%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RYTM's stock price target?
Price Target
128.38 USD

According to Wall Street analysts, the average 1-year price target for RYTM is 128.38 USD with a low forecast of 111.1 USD and a high forecast of 148.05 USD.

What is Rhythm Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
62%

The compound annual growth rate of Rhythm Pharmaceuticals Inc's revenue for the next 3 years is 62%.

Back to Top